Legacy Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $325K | Buy |
+3,140
| New | +$280K | 0.03% | 229 |
|
|
2026
Q1 | – | Sell |
-4,225
| Closed | -$335K | – | 289 |
|
|
2025
Q4 | $335K | Buy |
4,225
+925
| +28% | +$72.9K | 0.04% | 210 |
|
|
2025
Q3 | $249K | Buy |
+3,300
| New | +$226K | 0.03% | 219 |
|
|
2025
Q2 | – | Sell |
-7,608
| Closed | -$515K | – | 116 |
|
|
2025
Q1 | $515K | Buy |
7,608
+1,124
| +17% | +$67.3K | 0.05% | 258 |
|
|
2024
Q4 | $291K | Sell |
6,484
-436
| -6% | -$24.5K | 0.03% | 315 |
|
|
2024
Q3 | $435K | Buy |
6,920
+1,528
| +28% | +$89.1K | 0.05% | 254 |
|
|
2024
Q2 | $318K | Sell |
5,392
-15,191
| -74% | -$950K | 0.04% | 242 |
|
|
2024
Q1 | $1.64M | Sell |
20,583
-12,043
| -37% | -$920K | 0.21% | 90 |
|
|
2023
Q4 | $2.58M | Sell |
32,626
-14,867
| -31% | -$1.06M | 0.33% | 66 |
|
|
2023
Q3 | $3.32M | Sell |
47,493
-1,005
| -2% | -$71.2K | 0.53% | 42 |
|
|
2023
Q2 | $3.35M | Sell |
48,498
-1,306
| -3% | -$92.9K | 0.5% | 41 |
|
|
2023
Q1 | $3.7M | Buy |
49,804
+1,743
| +4% | +$146K | 0.68% | 35 |
|
|
2022
Q4 | $4.48M | Buy |
48,061
+4,395
| +10% | +$424K | 0.82% | 20 |
|
|
2022
Q3 | $4.16M | Buy |
43,666
+2,957
| +7% | +$293K | 0.92% | 16 |
|
|
2022
Q2 | $3.77M | Buy |
40,709
+4,025
| +11% | +$393K | 0.79% | 17 |
|
|
2022
Q1 | $3.71M | Buy |
36,684
+31,927
| +671% | +$3.35M | 0.72% | 20 |
|
|
2021
Q4 | $491K | Buy |
4,757
+949
| +25% | +$87.7K | 0.18% | 74 |
|
|
2021
Q3 | $323K | Buy |
3,808
+8
| +0.2% | +$670 | 0.13% | 91 |
|
|
2021
Q2 | $317K | Hold |
3,800
| – | – | 0.13% | 88 |
|
|
2021
Q1 | $286K | Hold |
3,800
| – | – | 0.13% | 90 |
|
|
2020
Q4 | $260K | Sell |
3,800
-1,809
| -32% | -$118K | 0.15% | 89 |
|
|
2020
Q3 | $328K | Buy |
5,609
+1,809
| +48% | +$113K | 0.22% | 76 |
|
|
2020
Q2 | $247K | Sell |
3,800
-4,000
| -51% | -$252K | 0.2% | 86 |
|
|
2020
Q1 | $463K | Sell |
7,800
-5,003
| -39% | -$334K | 0.46% | 55 |
|
|
2019
Q4 | $951K | Buy |
12,803
+4,755
| +59% | +$334K | 0.6% | 38 |
|
|
2019
Q3 | $508K | Buy |
8,048
+200
| +3% | +$11.9K | 0.38% | 56 |
|
|
2019
Q2 | $428K | Sell |
7,848
-9,964
| -56% | -$537K | 0.29% | 62 |
|
|
2019
Q1 | $960K | Buy |
17,812
+9,081
| +104% | +$560K | 0.31% | 69 |
|
|
2018
Q4 | $572K | Sell |
8,731
-18,763
| -68% | -$1.4M | 0.43% | 55 |
|
|
2018
Q3 | $2.16M | Buy |
27,494
+25,694
| +1,427% | +$1.84M | 1.07% | 21 |
|
|
2018
Q2 | $116K | Buy |
1,800
+1,775
| +7,100% | +$117K | 0.09% | 124 |
|
|
2018
Q1 | $2K | Buy |
+25
| New | +$1.79K | ﹤0.01% | 338 |
|
|
2017
Q4 | – | Sell |
-150
| Closed | -$12K | – | 366 |
|
|
2017
Q3 | $12K | Buy |
+150
| New | +$11.9K | 0.01% | 199 |
|
|
2017
Q1 | – | Sell |
-469
| Closed | -$37K | – | 208 |
|
|
2016
Q4 | $37K | Buy |
+469
| New | +$37.9K | 0.05% | 113 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
MIF
Legacy Advisors's CVS Position: Q2 2026 in Review
Legacy Advisors opened a new position in CVS Health (CVS) in Q2 2026: 3,140 shares worth $325K. The stake represents 0.03% of the portfolio and ranks #229 among its holdings. This is a return to the name: Legacy Advisors previously reported a position in CVS as recently as Q4 2025.
Legacy Advisors first reported a position in CVS in Q4 2016 and has held it in 34 quarters since. The position peaked at $4.48M in Q4 2022. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Legacy Advisors held 3,140 shares of CVS Health worth $325K as of Q2 2026.
- CVS Health was a new Legacy Advisors position in Q2 2026.
- CVS Health made up 0.03% of Legacy Advisors's portfolio in Q2 2026, its #229 holding.
- Legacy Advisors first reported a position in CVS Health in Q4 2016 and has held it in 34 quarters since.
- Legacy Advisors's CVS Health position peaked at $4.48M in Q4 2022.
- 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.